Hedgehog signaling in hepatocellular carcinoma: novel therapeutic strategy targeting hedgehog signaling in HCC.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Circular RNA Hsa_circ_0004018 Inhibits Wnt/β-Catenin Signaling Pathway by Targeting microRNA-626/DKK3 in Hepatocellular Carcinoma.OncoTargets and therapy · 2020
   Article
2. Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma.Targeted oncology · 2017
   Review
3. Cancer Stem Cell and Gastrointestinal Cancer: Current Status, Targeted Therapy and Future Implications.Biochemistry & pharmacology : open access · 2016
   Article
4. Targeted therapies in the treatment of advanced hepatocellular carcinoma.Clinical Medicine Insights. Oncology · 2013
   Article
5. Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions.Clinical & developmental immunology · 2012
   Review
6. Targeting metastatic upper gastrointestinal adenocarcinomas.World journal of clinical oncology · 2011
   Article
7. Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications.Journal of hepatology · 2010
   Review
8. Learning from Jekyll to control Hyde: Hedgehog signaling in development and cancer.Trends in molecular medicine · 2010
   Review
9. Molecular targeted therapies in hepatocellular carcinoma.Hepatology (Baltimore, Md.) · 2008
   Review
10. Systems Challenges of Hepatic Carcinomas: A Review.Journal of clinical and experimental hepatology
    Review

Corrections and comments

• Comment on
  Cisplatin-induced GADD34 upregulation potentiates oncolytic viral therapy in the treatment of malignant pleural mesothelioma.2006

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as